United Therapeutics Corporation (UTHR)
NASDAQ: UTHR · Real-Time Price · USD
435.84
+16.63 (3.97%)
Oct 1, 2025, 3:30 PM EDT - Market open

United Therapeutics Stock Forecast

Stock Price Forecast

The 15 analysts that cover United Therapeutics stock have a consensus rating of "Buy" and an average price target of $459.6, which forecasts a 5.45% increase in the stock price over the next year. The lowest target is $302 and the highest is $600.

Price Target: $459.6 (+5.45%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$302$459.6$463$600
Change-30.71%+5.45%+6.23%+37.67%

Analyst Ratings

The average analyst rating for United Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingApr '25May '25Jun '25Jul '25Aug '25Sep '25
Strong Buy666666
Buy223335
Hold444444
Sell000000
Strong Sell000000
Total121213131315

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
UBS
UBS
Strong Buy
Maintains
$560$580
Strong BuyMaintains$560$580+33.08%Sep 29, 2025
RBC Capital
RBC Capital
Buy
Initiates
$569
BuyInitiates$569+30.55%Sep 26, 2025
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$405$525
BuyMaintains$405$525+20.46%Sep 10, 2025
Oppenheimer
Oppenheimer
Buy
Maintains
$510$575
BuyMaintains$510$575+31.93%Sep 5, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$400$500
Strong BuyMaintains$400$500+14.72%Sep 5, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
3.27B
from 2.88B
Increased by 13.71%
Revenue Next Year
3.45B
from 3.27B
Increased by 5.38%
EPS This Year
28.07
from 24.64
Increased by 13.91%
EPS Next Year
29.10
from 28.07
Increased by 3.67%
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
1.48B1.69B1.94B2.33B2.88B3.27B3.45B
Revenue Growth
2.38%13.63%14.88%20.20%23.63%13.71%5.38%
EPS
11.5410.0615.0019.8124.6428.0729.10
EPS Growth
--12.83%49.11%32.07%24.38%13.91%3.67%
Forward PE
-----15.5314.98
No. Analysts
-----1717
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High3.4B3.7B
Avg3.3B3.4B
Low3.1B3.0B

Revenue Growth

Revenue Growth20252026202720282029
High
19.1%
13.3%
Avg
13.7%
5.4%
Low
6.5%
-8.0%

EPS Forecast

EPS20252026202720282029
High34.2033.14
Avg28.0729.10
Low24.7523.03

EPS Growth

EPS Growth20252026202720282029
High
38.8%
18.1%
Avg
13.9%
3.7%
Low
0.4%
-17.9%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.